Human drug hepatotoxicity: a contemporary clinical perspective

Drug-Induced Liver Injury Network (DILIN) Prospective Study

(2009) Robert J. Fontana et al.   DRUG SAFETY

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

(2008) Naga Chalasani et al.   GASTROENTEROLOGY

Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases

(2008) Allen D. Brinker et al.   HEPATOLOGY

GlutathioneS-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury

(2008) M. Isabel Lucena et al.   HEPATOLOGY

What is idiosyncratic hepatotoxicity? What is it not?

(2008) John R. Senior   HEPATOLOGY

Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury

(2008) James Rochon et al.   HEPATOLOGY

Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals

(2008) Craig Lammert et al.   HEPATOLOGY

Acute Liver Failure Including Acetaminophen Overdose

(2008) Robert J. Fontana   MEDICAL CLINICS OF NORTH AMERICA

Biomarkers of drug-induced adverse events

(2008) Donna L Mendrick et al.   Expert Review of Clinical Pharmacology

Clinical applications of pharmacogenomics to adverse drug reactions

(2008) Amalia M Issa   Expert Review of Clinical Pharmacology

Adverse drug reactions and pharmacogenomics: recent advances

(2007) Ana Alfirevic et al.   Personalized Medicine